World Tuberculosis (TB) Day takes place on 24th March and is designed to build awareness about the global epidemic of TB as well as the efforts and advances in eliminating the disease. TB is one of the leading causes of death from infectious diseases. The 24th March commemorates that day when Dr. Robert Koch announced that a small group of scientists at the University of Berlin’s Institute had discovered the cause of tuberculosis, the TB bacillus in 1882. This marked a turning point in the story of virulent human infectious diseases.
It is in this spirit that Frontiers is launching this Research Topic to coincide with this United Nations (UN) day. This occasion not only offers an opportunity to acknowledge and build awareness of the diseases but also to consider the importance of research in pharmacology and advances in treatment strategies.
This Frontiers in Pharmacology of Infectious Diseases Research Topic aims to address the pharmacology-specific dimensions highlighting the importance of treatment and considering how advancements in the field can further reduce this leading cause of death. Topics may include, but are by no means limited to:
1. Drug discovery, drug target discovery, new molecules and their evaluation
2. Pre-clinical pharmacology including both in vitro and in vivo studies
3. Clinical pharmacology including pharmacokinetics (PK), pharmacodynamics (PD), adverse drug reactions etc.
4. Modelling and simulation
5. Clinical trials evaluating TB treatment and interventions to optimize treatment
Manuscripts in the form of original research, reviews, mini reviews, systematic reviews, methods and opinions are welcome.
World Tuberculosis (TB) Day takes place on 24th March and is designed to build awareness about the global epidemic of TB as well as the efforts and advances in eliminating the disease. TB is one of the leading causes of death from infectious diseases. The 24th March commemorates that day when Dr. Robert Koch announced that a small group of scientists at the University of Berlin’s Institute had discovered the cause of tuberculosis, the TB bacillus in 1882. This marked a turning point in the story of virulent human infectious diseases.
It is in this spirit that Frontiers is launching this Research Topic to coincide with this United Nations (UN) day. This occasion not only offers an opportunity to acknowledge and build awareness of the diseases but also to consider the importance of research in pharmacology and advances in treatment strategies.
This Frontiers in Pharmacology of Infectious Diseases Research Topic aims to address the pharmacology-specific dimensions highlighting the importance of treatment and considering how advancements in the field can further reduce this leading cause of death. Topics may include, but are by no means limited to:
1. Drug discovery, drug target discovery, new molecules and their evaluation
2. Pre-clinical pharmacology including both in vitro and in vivo studies
3. Clinical pharmacology including pharmacokinetics (PK), pharmacodynamics (PD), adverse drug reactions etc.
4. Modelling and simulation
5. Clinical trials evaluating TB treatment and interventions to optimize treatment
Manuscripts in the form of original research, reviews, mini reviews, systematic reviews, methods and opinions are welcome.
